Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardio drugs
Biotech
Windtree's shock med raises blood pressure in latest phase 2 win
While Windtree has struggled to grow the financial roots to thrive, a win for its lead asset should give the company encouragement to persevere.
James Waldron
Sep 25, 2024 9:59am
Windtree's shock med rapidly raises blood pressure—and shares
Apr 20, 2022 10:38am
Amid AdComm rejection, Correvio Pharma hit with CRL
Dec 26, 2019 7:20pm
AHA: Caladrius therapy helps heart disease that hits women
Nov 18, 2019 8:33am
PhaseBio nets $34M to advance Brilinta reversal agent, PAH drug
Sep 5, 2018 8:00am
J&J taps PeptiDream for metabolic, cardiovascular R&D help
Apr 7, 2017 9:52am
